News & Events
May 2, 2018
̶ Companies will partner to advance multispecific antibodies in up to seven discrete projects, including one program against an undisclosed target currently in lead selection –
̶ Exelixis’ expansion into biologics builds upon history of success in the...
Invenra Announces Expansion of Collaboration with Exelixis
October 31, 2019
World Bispecific Antibody Summit
Advances in Immuno-Oncology USA Congress
San Diego, CA
Bryan Glaser, Vice President - Business Development, is a guest speaker.
Festival of Biologics 2019
National Harbor, Maryland
Mandar Bawadekar, Senior Scientist - Immunology, is a guest speaker.
Antibody Engineering & Therapeutics
Jonathan Davis, Head of Innovation, is a guest speaker.